adapalene lotion 0.1%

DRUG4 trials

Sponsors

Galderma R&D

Conditions

Acne VulgarisSkin Manifestations

Phase 1

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

CompletedNCT01046565

Galderma R&DSkin Manifestations

Start: 2010-01-31End: 2010-02-28Updated: 2022-08-25

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

CompletedNCT01046396

Galderma R&DSkin Manifestations

Start: 2010-01-31End: 2010-02-28Updated: 2022-08-01

Phase 3

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

CompletedNCT00598832

Galderma R&DAcne Vulgaris

Start: 2007-11-30End: 2008-11-30Updated: 2021-02-18

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

CompletedNCT00599521

Galderma R&DAcne Vulgaris

Start: 2007-11-30End: 2008-12-31Updated: 2021-02-18